Michael Hoxie
About Michael Hoxie
Michael Hoxie is a Molecular Technologist with expertise in next-generation sequencing and genetic analysis. He currently works at Orchid in the Raleigh-Durham-Chapel Hill Area and has held various positions in molecular technology and analysis since completing his degree in Biological Sciences at North Carolina State University.
Work at Orchid
Michael Hoxie currently serves as a Molecular Technologist at Orchid, a position he has held since 2022. In this role, he focuses on advanced embryo screening for in vitro fertilization (IVF) treatments, specifically identifying genetic risks associated with embryos. His expertise in next-generation sequencing (NGS) enhances the preconception screening process, contributing to improved outcomes in reproductive health.
Previous Experience in Molecular Technology
Prior to his current role, Michael Hoxie worked at Lighthouse Lab Services as a Molecular Technologist from 2021 to 2022. Before that, he was employed at Mako Medical as a Molecular Scientist for eight months in 2020. His experience in these positions has equipped him with a solid foundation in molecular technology and genetic analysis.
Education and Expertise
Michael Hoxie earned a Bachelor of Science degree in Biological Sciences with a focus on Human Biology from North Carolina State University. He completed his studies from 2014 to 2018. His educational background supports his specialization in next-generation sequencing (NGS) and single nucleotide polymorphism (SNP) genetic analysis, which are essential for assessing genetic health risks.
Career Background
Michael Hoxie's career began at Cedar Fair Entertainment Company, where he worked as a Ride Operations Associate from 2014 to 2015. He transitioned to the field of molecular technology, gaining experience in various roles that culminated in his current position at Orchid. His diverse work history reflects a progression from operational roles to specialized scientific positions.
Professional Skills
Michael Hoxie specializes in advanced embryo screening and genetic analysis techniques. His skills include conducting next-generation sequencing (NGS) and performing single nucleotide polymorphism (SNP) analysis. These competencies are critical for identifying genetic risks in embryos, thereby enhancing the effectiveness of IVF treatments.